Skip Links

Uncategorized

Uncategorized
IMC Applies to List its Common Shares on the NASDAQ Capital Market

Toronto, Canada; Glil Yam, Israel – October 8, 2020 – IM Cannabis Corp. (the “Company”

Read More ›

10/11/20

Uncategorized
IM Cannabis Accelerates Sales in Germany, Reaching Adjusted EBITDA Profitability

Shipments made to seven distribution partners in Germany German operations and growing sales by Focus

Read More ›

10/08/20

Uncategorized
Israeli Ministry of Health Opens International Export Market for Israeli Medical Cannabis Producers

Israeli Ministry of Health announced that it will begin accepting applications for a medical cannabis

Read More ›

10/06/20

Uncategorized
IM Cannabis Launches Sales of IMC-Branded Products in Germany, Adds to Pipeline of Purchase Agreements

IMC has now completed shipments of its branded flower products to four of the Company’s

Read More ›

09/24/20

Uncategorized
IM Cannabis Completes First Import into Germany, Further Strengthens Distribution Network

First shipment received into Germany from EU-GMP supply partner, allowing the Company to begin fulfilling

Read More ›

09/16/20

Uncategorized
IM Cannabis Reports 62% Increase in Consolidated Revenue and 54% Gross Margin in Q2 2020

Consolidated revenue increased to $3.8 million in Q2 2020, from $2.3 million in the prior

Read More ›

08/26/20

Uncategorized
IMC Announces Focus Medical Has Added Sixth Supplier Producing Under IMC Brand to Meet Growing Demand in Israel

Focus Medical has entered into a supply agreement with Israeli-based Ever Green for a potential

Read More ›

07/27/20

Uncategorized
IMC Continues German Market Expansion with Purchase Commitments from Three Additional Distribution Partners

IMC continues execution of German strategy with seven distribution agreements signed, adding axicorp, canymed and Materia  Now a total of 1,525kg of sales secured under binding purchase commitments in

Read More ›

07/23/20

Uncategorized
IMC Bolsters German Sales Network with Purchase Commitment from Zur Rose Pharma GmbH

IMC delivering on German strategy with fourth binding purchase commitment with distribution partner in Germany Zur

Read More ›

07/15/20

Uncategorized
IMC Announces Business Update and Review of Q2 Milestones

IMC has bolstered the network of pharmacies, distributors and supply partners that are supporting the

Read More ›

07/06/20

Uncategorized
IMC Reports Exercise of Warrants and Options

Adds $6.0 million to treasury, IMC fully funded for existing growth initiatives * Currency is in CAD$ unless

Read More ›

06/30/20

Uncategorized
IMC Announces Efficacy of IMC Branded Strains in Reducing Migraines

Peer-reviewed study indicates two IMC branded medical cannabis strains were effective in reducing migraines in

Read More ›

06/24/20

Uncategorized
IMC Announces Israeli Government Advancing Cannabis Decriminalization

Decriminalization framework passes first reading with Ministerial Committee on Legislation IMC in market leading position

Read More ›

06/22/20

Uncategorized
IMC Announces Focus Medical's First Import from Canada to Israel, Strengthening International Network

Strong relationships with Canadian medical cannabis industry are a strategic imperative to IMC as a

Read More ›

06/18/20

Uncategorized
IMC Announces Binding Term Sheet for Distribution of CannEpil® in Israel

New generation of evidence-based cannabis products to be launched in Israel IMC to be exclusive

Read More ›

06/15/20

Uncategorized
IMC Supports Israeli Government Action Towards Cannabis Decriminalization

TORONTO and GLIL YAM, Israel, June 10, 2020 /CNW/ – IM Cannabis Corp. (the “Company” or “IMC”) (CSE: IMCC), one

Read More ›

06/10/20

Uncategorized
IM Cannabis Releases Message from CEO and Recent Milestones

TORONTO and GLIL YAM, Israel, Jan. 6, 2020 /CNW/ – IM Cannabis Corp. (the “Company” or “IMC”) (CSE:IMCC), one

Read More ›

06/05/20

Uncategorized
IMC Announces Record Harvest by Focus Medical and Update on Israeli Operations

Focus Medical recently completed a semi-annual record harvest of over 3,000kg of medical cannabis Focus

Read More ›

06/04/20

Uncategorized
First Commercial Import Of IMC Branded Medical Cannabis From Spain Landed In Israel

IM Cannabis Corp (CSE: IMCC) IMCNF, an Israel-based medical cannabis company with European operations, made history this

Read More ›

06/04/20

Uncategorized
IMC Announces Focus Medical’s Successful Import of Medical Cannabis from Spain to Israel

Focus Medical has successfully imported approximately 200kg of medical cannabis from Spain into Israel The

Read More ›

05/26/20

Uncategorized
IMC Approved for 4,000kg of Medical Cannabis Import to Germany

IMC’s EU-GMP licensed subsidiary, Adjupharm, has been approved to import 4,000kg of medical cannabis into Germany from

Read More ›

05/19/20

Uncategorized
IMC Welcomes Approval of Medical Cannabis Exports by Israeli Government

Israeli Ministry of Economy signed a Free Export Order for medical cannabis products Government to

Read More ›

05/14/20

Uncategorized
IMC Signs Third Sales Agreement in Germany, Further Strengthening its Distribution Network

Executing on long-term strategy to build distribution platform across the large German market Sales commitment

Read More ›

05/12/20

Uncategorized
IMC Expands into German Market through Execution of Two Binding Sales Commitments

First step in a long-term strategy to develop a network of distribution partners in order

Read More ›

05/07/20

Uncategorized
IMC Cannabis Reports Q1/2020 Results and Strategic Milestones

Focus Medical has now entered into pharmacy sales agreements in Israel to deliver $193.5 million

Read More ›

05/06/20

Uncategorized
IMC Announces New Supplier Signed by Focus Medical, Now Five Suppliers Cultivating for Focus Medical under IMC Brand

Focus Medical has entered into a supply agreement to purchase up to a total 8,060kg

Read More ›

04/27/20

Uncategorized
IMC Announces Sales Agreement Signed by Focus Medical for $71.6 Million in Revenue and Gross Margin of 50%, Now $193.5 Million Under Binding Agreements

PharmYarok entered into a three-year binding sales agreement with Focus Medical for 12,600kg of medical

Read More ›

04/21/20

Uncategorized
IM Cannabis Reports 72% Increase in Q4 2019 Consolidated Revenue

Consolidated revenues increased 72% to $2.5 million in Q4 2019, fiscal 2019 consolidated revenue increased 75% with

Read More ›

04/20/20

Uncategorized
IMC Announces Two Additional Binding Sales Agreements by Focus Medical – Adds CAD$14.5 Million in Revenue with Gross Margin of 50% Over Three-Year Period

Focus Medical has entered into two additional binding sales agreements: Max Pharm for up to

Read More ›

04/16/20

Uncategorized
MC Announces Three-Year CAD$80.4 Million Sales Agreement with Gross Margin of 50% by Focus Medical with Super Pharm, Israel’s Largest Pharmacy Chain, for IMC-Branded Medical Cannabis Products

Focus Medical has entered into a three-year binding sales agreement with Super-Pharm, Israel’s largest pharmacy

Read More ›

04/13/20

Uncategorized
IMC Announces Second Focus Medical Deal for Sales of Branded Products in Israeli Pharmacy Channel for 2,000kg

Focus Medical, entered into a two-year binding agreement to sell 1,000kg of medical cannabis a

Read More ›

04/08/20

Uncategorized
IM Cannabis Provides Business Update on COVID-19

Israeli and German operations continue to advance strategic priorities, investments into innovation will be deferred

Read More ›

04/02/20

Uncategorized
IM Cannabis Adds New Partners for Supply of Medical Cannabis in Israel under IMC Brand

IMC continues to build asset-light business model to satisfy rising demand for medical cannabis in

Read More ›

03/31/20

Uncategorized
IM Cannabis to Expand IMC Brand in Pharmacies Across Israel

Focus Medical entered into a binding agreement to sell 800kg of medical cannabis a year

Read More ›

03/30/20

Uncategorized
IM Cannabis Bolsters Supply of Medical Cannabis in Israel under IMC Brand due to Definitive Supply Agreement between Focus and Intelicanna

Intelicanna, an Israeli cannabis company traded on the Tel Aviv Stock Exchange under the ticker

Read More ›

03/23/20

Uncategorized
IM Cannabis Corp. Announces Annual General Meeting Results

TORONTO and GLIL YAM, Israel, March 17, 2020 /CNW/ – IM Cannabis Corp. (the “Company” or “IMC“) (CSE: IMCC)

Read More ›

03/17/20

Uncategorized
Israeli Government Approves First Export of Medical Cannabis from Israel to United Kingdom

TORONTO and GLIL YAM, Israel, Jan. 30, 2020 /CNW/ – IM Cannabis Corp. (the “Company” or “IMC”) (CSE: IMCC), one

Read More ›

01/30/20

Uncategorized
IM Cannabis Continues European Expansion, Establishes Joint Venture and Supply Agreement in Greece

IMC to become 25% Joint Venture partner for cultivation and processing operation in Greece Preferred

Read More ›

01/28/20

Uncategorized
BofCLive with Oren Shuster, CEO, IMC Ltd.

Read More ›

01/26/20

Uncategorized
IM Cannabis Expands Innovation Portfolio

IM Cannabis Expands Innovation Portfolio with Investment in Xinteza to Develop Innovative Biosynthesis Technology based

Read More ›

01/07/20

Uncategorized
IM Cannabis Releases Message from CEO and Recent Milestones

Message from CEO 2019 was a pivotal year for IM Cannabis Corp. We are very

Read More ›

01/06/20

Uncategorized
IM Cannabis Corp. Provides Israeli Market Update

Toronto and Glil Yam, Israel, December 18, 2019 – IM Cannabis Corp. (the “Company” or

Read More ›

12/18/19

Uncategorized
Medical Marijuana Opportunity Out of Israel

Read More ›

12/12/19

Uncategorized
IMCC Appoints Yaron Berger as CEO of IMC Holdings

Berger brings over 10 years of experience in managing large-scale operations in the government and

Read More ›

12/06/19

Uncategorized
IM Cannabis to Host a Live Investor Webcast on December 10, 2019

IM Cannabis Corp. invites individual and institutional investors, as well as advisors and analysts, to

Read More ›

12/04/19

Uncategorized
Full interview: IM Cannabis eyes the European medical cannabis market as it lists on the CSE

Read More ›

12/01/19

Uncategorized
IMC Holdings Increases Consolidated Revenues by 70% in Third Quarter of 2019

Consolidated revenues increased 70% to $2.3 million as sales volume and patient count continue to

Read More ›

11/29/19

Uncategorized
IM Cannabis Warrants Begin Trading on CSE

TORONTO and GLIL YAM, Israel, Nov. 21, 2019 /CNW/ – IM Cannabis Corp. (the “Company” or “IMC“) (CSE: IMCC), one

Read More ›

11/21/19

Uncategorized
IM Cannabis Corp. Applies for Listing of Warrants on the CSE

TORONTO and GLIL YAM, Israel, Nov. 18, 2019 /CNW/ – IM Cannabis Corp. (formerly Navasota Resources Inc.) (the “Company” or

Read More ›

11/18/19

Uncategorized
IM Cannabis to Present at PI Financial Conference in London

TORONTO and GLIL YAM, Israel, Nov. 12, 2019 /CNW/ – IM Cannabis Corp. (the “Company” or “IMC”) (CSE:IMCC), one

Read More ›

11/12/19

Uncategorized
IM Cannabis to Become First Israeli Medical Cannabis Operator to List on CSE

IMC is the first Israeli medical cannabis company to list its shares in Canada and

Read More ›

11/05/19

Uncategorized
IM Cannabis to Become First Israeli Medical Cannabis Operator to List on CSE and Provides Update on Operations in Europe and Israel

IMC is the first Israeli medical cannabis company to list its shares in Canada and will trade

Read More ›

11/05/19

Uncategorized
IM Cannabis to Commence Trading on the CSE

Toronto and Glil Yam, Israel, October 31, 2019 – IM Cannabis Corp. (the “Company” or

Read More ›

10/31/19

Uncategorized
Israel New Cannabis Reform has Begun

  As of April 29st, 2019, the Israeli MOH Cannabis Reform will come into effect.

Read More ›

04/29/19

Uncategorized
IMC will Sponsor Cannatech

CannaTech is widely recognized as the premier cannabis event, designed to deliver the most sophisticated

Read More ›

03/29/19

Uncategorized
GAP Certification

Globally, regulators continue to set a high regulatory bar for cannabis growers in order to

Read More ›

02/05/19

Uncategorized
The Israeli Government has Approved Exportation of Medical Cannabis

On January 27th, 2019, the Israeli government finally approved the exportation of medical cannabis. Export

Read More ›

01/27/19

Uncategorized
Amendment to the Dangerous Drugs Ordinance

On December 25, 2018, Israel’s parliament passed a law that empowers the Israeli police to

Read More ›

01/05/19